Patents by Inventor Karel G. Odink

Karel G. Odink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cloning of a malarial gene
    Patent number: 5597708
    Abstract: The present invention relates to the P.195 gene of Plasmodium falciparum and, more specifically, to the cloning of that gene. The invention further relates to a method of producing the P.195 protein using the cloned gene. The invention also relates to a vaccine comprising the P.195 protein and to the use of same in the prophylaxis of malaria.
    Type: Grant
    Filed: December 2, 1993
    Date of Patent: January 28, 1997
    Assignee: Burroughs Wellcome Company
    Inventors: Anthony A. Holder, Michael J. Lockyer, Jasbir S. Sandhu, Valentina Riveros-Moreno, Karel G. Odink
  • Cytokine which mediates inflammation
    Patent number: 5411882
    Abstract: The invention concerns polypeptides with an apparent molecular weight of around 160 kD which are mediators or precursors for mediators of inflammation, derivatives thereof such as mutants and fragments, processes for their preparation, DNAs and hybrid vectors coding for said polypeptides and derivatives and host cells transformed with such hybrid vectors, polyclonal and monoclonal antibodies specific for said polypeptides or their derivatives and antibody derivatives as well as diagnostic and therapeutic methods for inflammatory conditions and Hodgkin lymphomas.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: May 2, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Karel G. Odink, Lajos Tarcsay, Josef Bruggen, Walter Wiesendanger, Nico Cerletti, Clemens Sorg, Christiane DeWolf-Peeters, Jan Delabie
  • Antibodies which bind to novel lymphokine related peptides
    Patent number: 5350687
    Abstract: The invention concerns polypeptides related to human macrophage migration inhibition factor, in particular the polypeptides called MRP-8 and MRP-14, processes for their preparation, mRNAs, DNAs and hybrid vectors coding for said polypeptides, hosts transformed with such a hybrid vector, monoclonal and polyclonal antibodies to said polypeptides , and diagnostic methods for inflammatory conditions and cystic fibrosis.
    Type: Grant
    Filed: November 21, 1990
    Date of Patent: September 27, 1994
    Assignee: Ciba-Geigy Corporation
    Inventors: Karel G. Odink, Roger Clerc, Nico Cerletti, Josef Bruggen, Lajos Tarcsay, Clemens Sorg, Walter Wiesendanger